NCT04442711 Cohort of IPF Patients Experiencing an Exacerbation
| NCT ID | NCT04442711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Gentofte, Copenhagen |
| Condition | Idiopathic Pulmonary Fibrosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2020-06-13 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2020-06-13 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension, patients are included if they experience an exacerbation, or other increase in respiratory symptoms requiring hospital admission, for further collection of clinical and biological data.
Eligibility Criteria
Inclusion Criteria: * Admitted with an increase in respiratory symptoms * Already included in PFBIO or included simultaneously in PFBIO and PFBIO-EXA * Age at least 18 years Exclusion Criteria: * Unable to provide informed consent
Frequently Asked Questions
Who can join the NCT04442711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Idiopathic Pulmonary Fibrosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04442711 currently recruiting?
Yes, NCT04442711 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Gentofte, Copenhagen to inquire about joining.
Where is the NCT04442711 trial being conducted?
This trial is being conducted at Hellerup, Denmark.
Who is sponsoring the NCT04442711 clinical trial?
NCT04442711 is sponsored by University Hospital, Gentofte, Copenhagen. The trial plans to enroll 50 participants.